Research Article
HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma
Article first published online: 18 MAY 2005
DOI: 10.1002/jmv.20361
Copyright © 2005 Wiley-Liss, Inc.
Additional Information
How to Cite
Dorak, M. T., Yee, L. J., Tang, J., Shao, W., Lobashevsky, E. S., Jacobson, L. P. and Kaslow, R. A. (2005), HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma. J. Med. Virol., 76: 302–310. doi: 10.1002/jmv.20361
Publication History
- Issue published online: 18 MAY 2005
- Article first published online: 18 MAY 2005
- Manuscript Accepted: 21 FEB 2004
Funded by
- National Institute of Health (NIH). Grant Numbers: R01-CA75957, R01-CA106168
- Center for AIDS Research (CFAR)
- School of Public Health at UAB
- National Institute of Allergy and Infectious Diseases
- National Cancer Institute. Grant Numbers: UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041
- Abstract
- References
- Cited By
Keywords:
- AIDS-related opportunistic infections;
- AIDS-related malignancies;
- case-control studies;
- polymorphism (genetics);
- genetic markers;
- HLA genes
Abstract
Polymorphisms of genes in the human leukocyte antigen (HLA) complex, particularly those encoding HLA-DR, have been suggested as markers of susceptibility to Kaposi's sarcoma (KS). We conducted a case-control study comparing 147 homosexual men who developed KS after infection by human immunodeficiency virus-1 (HIV-1) and human herpes virus 8 (HHV8) with 147 matched dually infected men without HIV-associated KS (HIV-KS) from the Multicenter AIDS Cohort Study. HLA-B, DRB1, DRB3, DRB4, DRB5, and DQB1 polymorphisms were examined by high-resolution DNA-based methods. Differences in distributions of genetic variants were tested by conditional logistic regression. Previously reported relationships with HLA-DRB1 alleles could not be confirmed. Instead, other associations were observed. In univariate analysis, KS was weakly associated with B*2702/5 (odds ratio (OR) = 0.40, 95% confidence interval (CI) = 0.18–0.91). Similar or stronger associations, positive or negative, were seen for haplotypes containing class II alleles: DRB1*1302-DQB1*0604 (OR = 3.67, 95% CI = 1.02–13.1), DRB4 (DR53) haplotype family members [OR = 0.52, 95% CI = 0.32–0.85], and DRB3 (DR52) haplotype family members (OR = 1.69, 95% CI = 1.07–2.67). The B*1402-DRB1*0102 haplotype, which invariably contains the V281L mutation in the 21-hydroxylase gene governing adrenal steroid biosynthesis, occurred in five cases and one control (OR = 5.0, 95% CI = 0.58–42.8). In a final multivariable analysis, only DRB1*1302-DQB1*0604 (OR = 6.43, 95% CI = 1.28–32.3, P = 0.02) remained significantly associated with KS. Associations of HLA-DRB families with HIV-KS could reflect underlying immune dysregulation. The HLA B*1402-DRB1*0102 haplotype associated with increased risk of KS might represent an antigen-presenting pathway unfavorable for immune response to HHV8. Alternatively, the relationship might hold a clue to the predilection of KS for men because that haplotype harbors the mutant form of the 21-hydroxylase gene. J. Med. Virol. 76:302–310, 2005. © 2005 Wiley-Liss, Inc.

1096-9071/asset/JMV_centre.gif?v=1&s=0cfbd8a2692b71d14e1d2a1936e4903513e31ac5)
1096-9071/asset/cover.gif?v=1&s=0dade998bc6232d09bc91c43270b9d2734a6bca3)